McKesson Acquires 80% of PRISM Vision for $850M

McKesson Corporation has signed a definitive agreement to acquire an 80 percent controlling interest in PRISM Vision Holdings, a leading provider of general ophthalmology and retina management services based in Berkeley Heights, New Jersey. The acquisition, valued at approximately $850 million, comes from private equity firm Quad-C, while PRISM Vision physicians will retain a 20 percent stake in the company.

Strategic Expansion into Ophthalmology and Retina Care

McKesson’s acquisition aims to strengthen its leadership in community-based specialty care, particularly in the high-growth retina and ophthalmology sector.

Brian Tyler, Chief Executive Officer of McKesson, emphasized the significance of this move in a company statement:

“The acquisition of PRISM Vision will allow McKesson to build on our leadership in community practice and specialty solutions, while building a platform to serve the high-growth area of retina and ophthalmology. PRISM Vision has a strong track record and value proposition for community-based physicians and a strong leadership team focused on delivering superior retinal care, enhancing the provider experience, and delivering innovative clinical research capabilities.”

PRISM Vision operates a broad ophthalmology network with over 180 providers across 91 office locations and seven ambulatory surgery centers. With a strong reputation in retinal care and a commitment to advancing clinical research, PRISM Vision aligns with McKesson’s strategy to enhance its specialty care offerings in ophthalmology.

Integration into McKesson’s U.S. Pharmaceutical Segment

Upon completion of the transaction, PRISM Vision Holdings will be consolidated within McKesson’s U.S. Pharmaceutical segment, further strengthening McKesson’s presence in the ophthalmology and retina market.

Conclusion

This acquisition underscores McKesson’s commitment to expanding specialty healthcare services and investing in high-growth therapeutic areas like retina and ophthalmology. By integrating PRISM Vision’s expertise and extensive provider network, McKesson aims to enhance patient care, improve provider experiences, and drive innovation in retinal disease management.